| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |